-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Background: Type 2 diabetes affects nearly 540 million people worldwide who are known to suffer from complications such as chronic kidney disease, heart failure, coronary ischemic disease, stroke and peripheral arterial disease, and diabetes-related microvascular disease complications
Background: Type 2 diabetes affects nearly 540 million people worldwide who are known to suffer from complications such as chronic kidney disease, heart failure, coronary ischemic disease, stroke and peripheral arterial disease, and diabetes-related microvascular disease complications
In order to develop health policy that directs resources to where the human and societal burden of type 2 diabetes-related complications is greatest, it is necessary to understand which forms of CVRD most often occur first in previously unaffected low-risk populations, and which forms in It recurs most often thereafter
OBJECTIVE: The aim of this study was to extend this study to detail the incidence of CVRD in contemporary T2DM populations in North America, Europe and other Asian countries, initially excluding CVRD
Methods: Data were obtained from digital health care systems in 12 countries using pre-specified protocols
Results: 1.
Figure 1 Country and distribution of 1.
Figure 1 Country and distribution of 1.
Figure 2 Cumulative incidence of cardiovascular and renal disease in 1.
Figure 2 Cumulative incidence of cardiovascular and renal disease in 1.
Figure 3 Detailed proportions of all cardiovascular and renal disease (CVRD) manifestations (180,000 [15.
Figure 3 Detailed proportions of all cardiovascular and renal disease (CVRD) manifestations (180,000 [15.
Figure 4
Figure 4
Figure 5.
Figure 5.
CONCLUSIONS: Heart failure or chronic kidney disease were the most common CVRD manifestations in people at low risk for T2D in all countries; accounting for the highest proportion of hospital health care costs
.
These new findings underscore the importance of cardiorenal awareness when planning health care
.
Across all countries, heart failure or chronic kidney disease were the most common CVRD manifestations in people at low risk for T2D; accounting for the highest proportion of hospital health care costs
.
These new findings underscore the importance of cardiorenal awareness when planning health care
.
Original source: Norhammar A, Bodegard J, Eriksson JW, et al.
Cost of healthcare utilization associated with incident cardiovascular and renal disease in individuals with type 2 diabetes: a multinational, observational study across 12 countries.
Diabetes Obes Metab 2022 Mar 23
Cost of healthcare utilization associated with incident cardiovascular and renal disease in individuals with type 2 diabetes: a multinational, observational study across 12 countries.
Diabetes Obes Metab 2022 Mar 23 Cost of healthcare utilization associated with incident cardiovascular and renal disease in individuals with type 2 diabetes: a multinational, observational study across 12 countries.
Leave a comment here
